Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STRP
1776
CALL
DELISTED
Straight Path Communications Inc.
STRP
| $2.46M | ﹤0.01% |
+75,000
| New | +$1.83M |
|
1777
Vince Holding Corp
VNCE
$79.1M
| $2.45M | ﹤0.01% |
20,465
-9,187
| -31% | -$1.54M |
|
1778
J.M. Smucker
SJM
$14.1B
| $2.45M | ﹤0.01% |
+22,597
| New | +$2.61M |
|
|
TIVO
1779
DELISTED
Tivo Inc
TIVO
| $2.45M | ﹤0.01% |
153,593
-1,221,722
| -89% | -$21.4M |
|
|
CHU
1780
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $2.44M | ﹤0.01% |
155,687
-129,158
| -45% | -$2.26M |
|
|
WWAV
1781
CALL
DELISTED
The WhiteWave Foods Company
WWAV
| $2.44M | ﹤0.01% |
+50,000
| New | +$2.34M |
|
|
IBKC
1782
DELISTED
IBERIABANK Corp
IBKC
| $2.43M | ﹤0.01% |
35,662
+4,090
| +13% | +$268K |
|
1783
Mativ Holdings
MATV
$700M
| $2.43M | ﹤0.01% |
60,934
+42,945
| +239% | +$1.82M |
|
|
PNNT
1784
Pennant Park Investment Corp
PNNT
$251M
| $2.43M | ﹤0.01% |
276,304
+107,318
| +64% | +$1.01M |
|
1785
CALL
Verizon
VZ
$208B
| $2.42M | ﹤0.01% |
+52,000
| New | +$2.55M |
|
1786
Pegasystems
PEGA
$5.63B
| $2.42M | ﹤0.01% |
211,188
-204,294
| -49% | -$2.26M |
|
|
ITCI
1787
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.41M | ﹤0.01% |
+75,400
| New | +$1.91M |
|
1788
Aegon
AEG
$13.8B
| $2.41M | ﹤0.01% |
+462,469
| New | +$2.51M |
|
|
CTLP
1789
DELISTED
Cantaloupe
CTLP
| $2.4M | ﹤0.01% |
890,535
-101,965
| -10% | -$300K |
|
|
UNIT
1790
Uniti Group
UNIT
$2.47B
| $2.39M | ﹤0.01% |
+96,711
| New | +$2.61M |
|
|
VXZ
1791
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
| $2.39M | ﹤0.01% |
53,349
+6,017
| +13% | +$278K |
|
1792
State Street Materials Select Sector SPDR ETF
XLB
$8.96B
| $2.38M | ﹤0.01% |
98,428
-79,146
| -45% | -$1.99M |
|
1793
AngioDynamics
ANGO
$652M
| $2.37M | ﹤0.01% |
144,362
+4,154
| +3% | +$69K |
|
|
LBRDK
1794
DELISTED
Liberty Broadband Class C
LBRDK
| $2.37M | ﹤0.01% |
46,237
-43,012
| -48% | -$2.29M |
|
1795
Materion
MTRN
$4.94B
| $2.37M | ﹤0.01% |
67,098
-40,118
| -37% | -$1.55M |
|
1796
WisdomTree Japan Hedged Equity Fund
DXJ
$7.3B
| $2.36M | ﹤0.01% |
41,292
-1,338
| -3% | -$77.6K |
|
1797
Scorpio Tankers
STNG
$3.8B
| $2.36M | ﹤0.01% |
23,407
+4,884
| +26% | +$469K |
|
1798
Kopin
KOPN
$916M
| $2.36M | ﹤0.01% |
684,043
+58,715
| +9% | +$210K |
|
|
ARO
1799
DELISTED
Aeropostale Inc
ARO
| $2.36M | ﹤0.01% |
1,456,113
+1,391,205
| +2,143% | +$3.67M |
|
|
ENZ
1800
DELISTED
Enzo Biochem, Inc.
ENZ
| $2.36M | ﹤0.01% |
777,684
+35,874
| +5% | +$101K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.